philochem
 
About-us technologies products Clinical-trials collaborations news careers contact-us
 
About Philogen
 

Philogen is a Swiss-Italian integrated biotechnology company founded in 1996, with the mission to develop innovative biopharmaceuticals for the treatment of angiogenesis-related disorders.....>>>

 
About Philochem
 

Philochem is a fully owned daughter company of Philogen and represents the Discovery Unit of the Philogen group.

Philochem is based in Otelfingen (Zurich, Switzerland).>>

 
Recent News

Zürich (Switzerland),
3rd March, 2015

Philochem announces the publication in the prestigious journal Nature Chemistry of an article entitled 'Dual-display of small molecules enables the discovery of ligand pairs and facilitates affinity maturation'.
(see full press release)

 
Upcoming Events

Rome (Italy),
10th-13th June, 2015

Philogen will present "Dekavil (F8-IL10), a novel therapeutic approach for rheumatoid arthritis: ongoing Phase Ib clinical trial results." at EULAR Rome 2015.